For instance, molecular epidemiological studies have highlighted the close association between CD28/cytotoxic T‐lymphocyte‐associated protein 4/inducible costimulator (ICOS) polymorphisms and susceptibility to RA in patients [11]. Here, ICOS is linked to rheumatoid arthritis.